FDA inspection
Fisher Wallace Laboratories Inc.: FDA inspection ending Mar 15, 2023
FDA inspection 1199962 · Voluntary Action Indicated (VAI) · Brooklyn, NY
Key facts
| Inspection ID | 1199962 |
|---|---|
| Firm | Fisher Wallace Laboratories Inc. |
| FEI number | 3006258094 |
| Address | 630 Flushing Ave Ste 104 |
| City | Brooklyn |
| State | NY |
| ZIP | 11206 |
| Country | United States |
| Fiscal year | 2023 |
| Inspection end date | Mar 15, 2023 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Compliance: Devices |
| Product type | Devices |
At a glance
- 10–99 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data